Strategy
MSTR
MARA Holdings
MARA
Tesla
TSLA
Coinbase
COIN
Apple
AAPL
US Stock MarketDetailed Quotes
NTRA Natera
- 155.590
- -1.020-0.65%
Close Feb 28 16:00 ET
- 157.000
- +1.410+0.91%
Post 20:01 ET
21.03BMarket Cap-101.69P/E (TTM)
165.000High150.000Low9.86MVolume159.940Open156.610Pre Close1.54BTurnover7.55%Turnover RatioLossP/E (Static)135.19MShares183.00052wk High17.59P/B20.31BFloat Cap83.13052wk Low--Dividend TTM130.55MShs Float183.000Historical High--Div YieldTTM9.58%Amplitude6.520Historical Low155.902Avg Price1Lot Size
About Natera Company
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.
Company Profile
SymbolNTRA
Company NameNatera
Listing DateJul 2, 2015
Issue Price18.00
Founded2003
CEOMr. Steven Leonard Chapman
MarketNASDAQ
Employees3293
Fiscal Year Ends12-31
AddressBuilding A, 13011 McCallen Pass,Suite 100
CityAustin
ProvinceTexas
CountryUnited States of America
Zip Code78753
Phone1-650-980-9190
Websitehttp://www.natera.com
Company Executives
- Name
- Position
- Salary
- Steven Leonard Chapman
- Director, Chief Executive Officer and Co-President
- 12.73M
- Michael Brophy
- Chief Financial Officer and Principal Accounting Officer
- 5.07M
- John Fesko
- Co-President and Chief Business Officer
- --
- Daniel Rabinowitz
- Secretary and Chief Legal Officer
- 3.33M
- Dr. Matthew Rabinowitz
- Executive Chairman of the Board
- 8.97M
- Solomon Moshkevich
- President, Clinical Diagnostics
- --
- Jonathan Sheena
- Director
- --
- Herm Rosenman
- Independent Director
- 339.16K
- Dr. Rowan E. Chapman, PhD
- Independent Director
- 338.72K
- Dr. James I. Healy, M.D.,PhD
- Independent Director
- 329.64K
- Roelof Frederik Botha
- Lead Independent Director
- 350.98K
- Dr. Roy D. Baynes, M.D.,PhD
- Independent Director
- 317.73K
- Ruth W. Brinkley
- Independent Director
- --
- Dr. Gail B. Marcus
- Independent Director
- 337.22K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.